Company Profile
Year Established :
1998
Total Number of Staff :
more than 1000
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Hybio Pharmaceutical Co., Ltd., established in Jun 1998, is a national high-tech enterprise specializing in the research, production, and sales of peptide pharmaceuticals. The company was listed on the Shenzhen Stock Exchange in 2011 (stock code: 300199) and it is distinguished as the first peptide enterprise listed in China. With subsidiaries in Pingshan, Wuhan, Hong Kong, Gansu Chengji, and Dali, Han Yu Pharmaceuticals operates in the fields of pharmaceuticals and medical devices. Our main products include peptide raw materials, custom peptides, cosmetic peptides, peptide formulations, solid dosage forms, medical devices, and peptide skincare products.
Sixteen years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
